US FDA revokes authorization for four COVID antibody drugs
The U.S. Food and Drug Administration has revoked the emergency use authorization for four COVID-19 antibody-based drugs, ...
FDA revokes EUAs for some antibody treatments for COVID-19
The U.S. Food and Drug Administration has revoked the Emergency Use Authorization for bamlanivimab administered alone, bamlanivimab and ...
Hosted on MSN7d
EMA Panel Endorses Lilly's Omvoh for Expanded Use in Crohn's Disease
Eli Lilly LLY announced that the EMA’s Committee for Medicinal Products for Human Use (“CHMP”) recommended approving its ...
Eli Lilly ‘commends’ ITC ruling cracking down on unlawful tirzepatide imports
In a win for patients, the judge overseeing Lilly’s International Trade Commission case determined that U.S. Customs ...
STAT12d
Eli Lilly’s new maneuvers in GLP-1 treatment
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, hope everyone is ...
ABC News3d
FDA approves Eli Lilly’s obesity medication for obstructive sleep apnea
In a study, people who took Zepbound had fewer breathing interruptions. The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe ...
Eli Lilly Gets FDA Approval for Zepbound for Certain Sleep Apnea Patients
Eli Lilly said the FDA approved Zepbound for moderate-to-severe obstructive sleep apnea in adults with obesity, the first and ...
FiercePharma13d
High-flying Eli Lilly plots $15B share buyback campaign
With Eli Lilly's diabetes and obesity products Mounjaro and Zepbound booming in popularity, the drugmaker finds itself in a ...
Yahoo3d
The FDA just approved Eli Lilly's Zepbound for sleep apnea — and Medicare coverage could be next
Eli Lilly (LLY) announced today that its blockbuster weight-loss drug Zepbound was approved by the U.S. Food and Drug Administration (FDA) as the first prescription drug to help alleviate moderate ...